Wockhardt shareholders reject resolution on related party transaction Ruchika Sharma18 Aug 2023 1:30 PM ISTNew Delhi: Shareholders of pharma firm Wockhardt Ltd have rejected a resolution on a related party transaction that seeks to allow the company to...
Wockhardt Former executive banned from securities market for six months for insider trading Ruchika Sharma21 Jun 2023 3:30 PM ISTNew Delhi: Sebi has barred Yatendra Kumar, a former executive of Wockhardt Ltd, from the securities market for six months and directed him to disgorge...
Present More Data on drug abuse potential of Tapentadol: CDSCO tells Wockhardt for FDC Dicyclomine,Tapentadol Dr. Divya Colin8 March 2023 5:15 PM ISTNew Delhi: Regarding the fixed dose combination (FDC) drug Dicyclomine plus Tapentadol, the Subject Expert Committee (SEC) functional under the...
Wockhardt plans to roll out two vaccines within year from UK facility as part of a tie-up with SII Ruchika Sharma27 Feb 2023 2:30 PM ISTNew Delhi: Drug firm Wockhardt plans to roll out two vaccines within a year from its UK-based facility as part of a tie-up with Serum Institute...
Wockhardt reports consolidated loss after tax of Rs 102 crore in Q3 Ruchika Sharma14 Feb 2023 11:15 AM ISTDuring the quarter, revenue from India business stood at Rs 175 crore while that of UK was at Rs 223 crore.
Continued pricing pressures in US, European Markets to affect profit margins of Indian pharma firms: Ratings agency ICRA Ruchika Sharma6 Jan 2023 2:30 PM ISTICRA said most major Indian pharmaceutical companies continue to focus on emerging markets to fuel their growth, given that they continue to face...
Wockhardt begins Global Phase 3 clinical study of novel antibiotic WCK 5222 Ruchika Sharma17 Aug 2022 12:00 PM ISTWCK 5222 is being developed to treat serious Gram-negative bacterial infections which are becoming increasingly resistant to antibiotics and pose a...
Wockhardt , Serum Life Sciences collaborate for manufacturing multiple vaccines MD Bureau21 March 2022 12:54 PM ISTThis collaboration between a subsidiary of Wockhardt and Serum Life Sciences UK will help create considerable number of employment opportunities...
Wockhardt sets issue price at Rs 225 per share for Rs 748-cr rights issue MD Bureau5 March 2022 1:21 PM ISTThe issue price has been fixed at Rs 225 per fully paid-up equity share, including a premium of Rs 220 per share.
CDSCO nod to Wockhardt for exporting up to 100 million Sputnik doses Ruchika Sharma8 Feb 2022 3:30 PM ISTMumbai: Wockhardt Limited, a global Pharmaceutical and Biotechnology Company headquartered in India, on Tuesday said that it has received permission...
Wockhardt net profit jumps over 11-fold to Rs 37.17 crore in Q2 Ruchika Sharma9 Nov 2021 11:30 PM ISTNew Delhi: Drug firm Wockhardt on Monday reported an over 11-fold jump in its consolidated net profit to Rs 37.17 crore for the quarter ended...
NPPA fixes retail price of 23 formulations; details Medical Dialogues Team27 Sept 2021 4:37 PM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India,...
